Xconomy | Boston - Business + Technology in the Exponential Economy

Related Posts

Biotech, Life Sciences, Real Estate

Alkermes Moving to Waltham

Luke Timmerman 4/22/09

Alkermes, the Cambridge, MA-based developer of anti-addiction drugs, said today it has signed a lease to move its headquarters to Waltham, MA. The company (NASDAQ: ALKS), which has more than 600 employees, plans to complete the move in early 2010. The move is supposed to save the company $8 million a year starting in fiscal 2011.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.